vs
欧加隆（OGN）与UNIVERSAL CORP（UVV）财务数据对比。点击上方公司名可切换其他公司
欧加隆的季度营收约是UNIVERSAL CORP的1.8倍（$1.5B vs $853.2M），UNIVERSAL CORP净利率更高（3.9% vs -13.6%，领先17.5%），欧加隆同比增速更快（-5.3% vs -8.1%），欧加隆自由现金流更多（$96.0M vs $95.1M），过去两年UNIVERSAL CORP的营收复合增速更高（6.2% vs -3.6%）
欧加隆是一家总部位于美国新泽西州泽西城的制药企业，核心业务覆盖生殖医学、避孕、精神科、激素替代疗法及麻醉领域的药物研发与生产。公司所有产品均在美国境外生产，同时美国市场贡献了其三分之一的营收。
环球技术学院（UTI）是美国一家营利性私立技术院校体系，由罗伯特·斯威特于1965年创立，专注于为全美各地学生提供专业职业技术教育培训。
OGN vs UVV — 直观对比
营收规模更大
OGN
是对方的1.8倍
$853.2M
营收增速更快
OGN
高出2.7%
-8.1%
净利率更高
UVV
高出17.5%
-13.6%
自由现金流更多
OGN
多$885.0K
$95.1M
两年增速更快
UVV
近两年复合增速
-3.6%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $853.2M |
| 净利润 | $-205.0M | $33.2M |
| 毛利率 | 49.2% | 17.8% |
| 营业利润率 | -9.8% | 9.6% |
| 净利率 | -13.6% | 3.9% |
| 营收同比 | -5.3% | -8.1% |
| 净利润同比 | -288.1% | -44.2% |
| 每股收益（稀释后） | $-0.78 | $1.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OGNUVV
| Q4 25 | $1.5B | $853.2M | ||
| Q3 25 | $1.6B | $749.4M | ||
| Q2 25 | $1.6B | $592.6M | ||
| Q1 25 | $1.5B | $690.2M | ||
| Q4 24 | $1.6B | $928.0M | ||
| Q3 24 | $1.6B | $708.4M | ||
| Q2 24 | $1.6B | $596.4M | ||
| Q1 24 | $1.6B | $756.3M |
净利润OGNUVV
| Q4 25 | $-205.0M | $33.2M | ||
| Q3 25 | $160.0M | $34.2M | ||
| Q2 25 | $145.0M | $8.5M | ||
| Q1 25 | $87.0M | $9.3M | ||
| Q4 24 | $109.0M | $59.6M | ||
| Q3 24 | $359.0M | $25.9M | ||
| Q2 24 | $195.0M | $130.0K | ||
| Q1 24 | $201.0M | $40.3M |
毛利率OGNUVV
| Q4 25 | 49.2% | 17.8% | ||
| Q3 25 | 53.5% | 18.0% | ||
| Q2 25 | 54.8% | 19.1% | ||
| Q1 25 | 55.6% | 15.1% | ||
| Q4 24 | 56.3% | 19.9% | ||
| Q3 24 | 58.3% | 19.9% | ||
| Q2 24 | 58.4% | 16.0% | ||
| Q1 24 | 59.0% | 18.0% |
营业利润率OGNUVV
| Q4 25 | -9.8% | 9.6% | ||
| Q3 25 | 15.2% | 9.0% | ||
| Q2 25 | 14.4% | 5.7% | ||
| Q1 25 | 6.7% | 6.2% | ||
| Q4 24 | 8.1% | 11.2% | ||
| Q3 24 | 13.1% | 9.7% | ||
| Q2 24 | 14.6% | 2.9% | ||
| Q1 24 | 14.5% | 9.0% |
净利率OGNUVV
| Q4 25 | -13.6% | 3.9% | ||
| Q3 25 | 10.0% | 4.6% | ||
| Q2 25 | 9.1% | 1.4% | ||
| Q1 25 | 5.8% | 1.4% | ||
| Q4 24 | 6.8% | 6.4% | ||
| Q3 24 | 22.7% | 3.7% | ||
| Q2 24 | 12.1% | 0.0% | ||
| Q1 24 | 12.4% | 5.3% |
每股收益（稀释后）OGNUVV
| Q4 25 | $-0.78 | $1.32 | ||
| Q3 25 | $0.61 | $1.36 | ||
| Q2 25 | $0.56 | $0.34 | ||
| Q1 25 | $0.33 | $0.37 | ||
| Q4 24 | $0.42 | $2.37 | ||
| Q3 24 | $1.38 | $1.03 | ||
| Q2 24 | $0.75 | $0.01 | ||
| Q1 24 | $0.78 | $1.62 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $574.0M | $85.2M |
| 总债务越低越好 | $8.6B | — |
| 股东权益账面价值 | $752.0M | $1.5B |
| 总资产 | $12.9B | $3.0B |
| 负债/权益比越低杠杆越低 | 11.49× | — |
8季度趋势，按日历期对齐
现金及短期投资OGNUVV
| Q4 25 | $574.0M | $85.2M | ||
| Q3 25 | $672.0M | $88.7M | ||
| Q2 25 | $599.0M | $178.4M | ||
| Q1 25 | $547.0M | $260.1M | ||
| Q4 24 | $675.0M | $215.1M | ||
| Q3 24 | $763.0M | $80.1M | ||
| Q2 24 | $704.0M | $101.7M | ||
| Q1 24 | $575.0M | $55.6M |
总债务OGNUVV
| Q4 25 | $8.6B | — | ||
| Q3 25 | $8.8B | — | ||
| Q2 25 | $8.9B | — | ||
| Q1 25 | $9.0B | — | ||
| Q4 24 | $8.9B | — | ||
| Q3 24 | $8.7B | — | ||
| Q2 24 | $8.7B | — | ||
| Q1 24 | $8.7B | — |
股东权益OGNUVV
| Q4 25 | $752.0M | $1.5B | ||
| Q3 25 | $906.0M | $1.5B | ||
| Q2 25 | $733.0M | $1.5B | ||
| Q1 25 | $542.0M | $1.5B | ||
| Q4 24 | $472.0M | $1.5B | ||
| Q3 24 | $493.0M | $1.4B | ||
| Q2 24 | $144.0M | $1.4B | ||
| Q1 24 | $48.0M | $1.4B |
总资产OGNUVV
| Q4 25 | $12.9B | $3.0B | ||
| Q3 25 | $13.6B | $3.1B | ||
| Q2 25 | $13.5B | $3.2B | ||
| Q1 25 | $13.2B | $3.0B | ||
| Q4 24 | $13.1B | $3.0B | ||
| Q3 24 | $12.8B | $3.0B | ||
| Q2 24 | $12.2B | $3.0B | ||
| Q1 24 | $11.9B | $2.9B |
负债/权益比OGNUVV
| Q4 25 | 11.49× | — | ||
| Q3 25 | 9.74× | — | ||
| Q2 25 | 12.14× | — | ||
| Q1 25 | 16.52× | — | ||
| Q4 24 | 18.81× | — | ||
| Q3 24 | 17.75× | — | ||
| Q2 24 | 60.11× | — | ||
| Q1 24 | 181.54× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $141.0M | $114.3M |
| 自由现金流经营现金流 - 资本支出 | $96.0M | $95.1M |
| 自由现金流率自由现金流/营收 | 6.4% | 11.1% |
| 资本支出强度资本支出/营收 | 3.0% | 2.3% |
| 现金转化率经营现金流/净利润 | — | 3.44× |
| 过去12个月自由现金流最近4个季度 | $538.0M | $52.7M |
8季度趋势，按日历期对齐
经营现金流OGNUVV
| Q4 25 | $141.0M | $114.3M | ||
| Q3 25 | $264.0M | $32.7M | ||
| Q2 25 | $220.0M | $-205.1M | ||
| Q1 25 | $75.0M | $158.7M | ||
| Q4 24 | $390.0M | $215.6M | ||
| Q3 24 | $141.0M | $15.0M | ||
| Q2 24 | $332.0M | $-62.4M | ||
| Q1 24 | $76.0M | $-27.9M |
自由现金流OGNUVV
| Q4 25 | $96.0M | $95.1M | ||
| Q3 25 | $218.0M | $23.7M | ||
| Q2 25 | $181.0M | $-217.2M | ||
| Q1 25 | $43.0M | $151.0M | ||
| Q4 24 | $335.0M | $199.6M | ||
| Q3 24 | $99.0M | $-1.0M | ||
| Q2 24 | $300.0M | $-85.2M | ||
| Q1 24 | $30.0M | $-46.2M |
自由现金流率OGNUVV
| Q4 25 | 6.4% | 11.1% | ||
| Q3 25 | 13.6% | 3.2% | ||
| Q2 25 | 11.4% | -36.6% | ||
| Q1 25 | 2.8% | 21.9% | ||
| Q4 24 | 21.0% | 21.5% | ||
| Q3 24 | 6.3% | -0.1% | ||
| Q2 24 | 18.7% | -14.3% | ||
| Q1 24 | 1.8% | -6.1% |
资本支出强度OGNUVV
| Q4 25 | 3.0% | 2.3% | ||
| Q3 25 | 2.9% | 1.2% | ||
| Q2 25 | 2.4% | 2.0% | ||
| Q1 25 | 2.1% | 1.1% | ||
| Q4 24 | 3.5% | 1.7% | ||
| Q3 24 | 2.7% | 2.3% | ||
| Q2 24 | 2.0% | 3.8% | ||
| Q1 24 | 2.8% | 2.4% |
现金转化率OGNUVV
| Q4 25 | — | 3.44× | ||
| Q3 25 | 1.65× | 0.96× | ||
| Q2 25 | 1.52× | -24.14× | ||
| Q1 25 | 0.86× | 17.00× | ||
| Q4 24 | 3.58× | 3.62× | ||
| Q3 24 | 0.39× | 0.58× | ||
| Q2 24 | 1.70× | -480.34× | ||
| Q1 24 | 0.38× | -0.69× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OGN
暂无分部数据
UVV
| Tobacco Operations | $779.9M | 91% |
| Service Other | $36.7M | 4% |
| Other | $17.8M | 2% |
